clinical trial · NCT06920745
TriClip CED RWE Study
Abbott Medical Devices·—·recruiting·n = 2,200
Tricuspid RegurgitationThe TriClip System
brief summary
This Coverage with Evidence Development (CED) study evaluates the long-term health outcomes of patients with symptomatic, severe or greater Tricuspid Regurgitation who received a Tricuspid Transcatheter Edge-to-Edge Repair (T-TEER) procedure using the TriClip system.
started
Jul 8, 2025
primary completion
Jul 1, 2032
completion
Jul 1, 2032
last updated
Aug 11, 2025
detailed description
The TRICARE will assess 2-year effectiveness in patients with symptomatic, severe or greater TR who undergo Tricuspid Transcatheter Edge-to-Edge Repair (T-TEER) with the TriClip system, as compared to a contemporaneous control of patients without T-TEER.
official title
TRIClip CoverAge With Evidence Development (CED) Real-World Evidence (RWE) Study (TRICARE)
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol